Washington Trust Bank’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-25
Closed -$3K 1030
2016
Q3
$3K Buy
25
+4
+19% +$461 ﹤0.01% 649
2016
Q2
$3K Buy
+21
New +$2.54K ﹤0.01% 689
2014
Q4
Sell
-1,405
Closed -$206K 848
2014
Q3
$206K Buy
1,405
+275
+24% +$42.5K 0.06% 210
2014
Q2
$189K Hold
1,130
0.04% 241
2014
Q1
$224K Buy
1,130
+1,100
+3,667% +$208K 0.05% 204
2013
Q4
$216 Buy
+30
New +$5.58K 0.39% 129

Other funds holding CLB

Washington Trust Bank's CLB Position: Q4 2016 in Review

Washington Trust Bank sold out of Core Laboratories (CLB) in Q4 2016, closing a stake of 25 shares — an estimated $3K sold.

Washington Trust Bank first reported a position in CLB in Q4 2013 and held it in 6 quarters. The position peaked at $224K in Q1 2014. 372 funds tracked by Wall St. Rank hold CLB as of Q4 2016.

  • Washington Trust Bank reported no remaining Core Laboratories position as of Q4 2016 after selling out during the quarter.
  • Washington Trust Bank sold 25 Core Laboratories shares in Q4 2016, an estimated $3K.
  • Washington Trust Bank first reported a position in Core Laboratories in Q4 2013 and held it in 6 quarters.
  • Washington Trust Bank's Core Laboratories position peaked at $224K in Q1 2014.
  • 372 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.

Based on Washington Trust Bank's 13F filing for Q4 2016, filed 17 Jan 2017.